AU2225297A - Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7 - Google Patents

Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7

Info

Publication number
AU2225297A
AU2225297A AU22252/97A AU2225297A AU2225297A AU 2225297 A AU2225297 A AU 2225297A AU 22252/97 A AU22252/97 A AU 22252/97A AU 2225297 A AU2225297 A AU 2225297A AU 2225297 A AU2225297 A AU 2225297A
Authority
AU
Australia
Prior art keywords
therapeutic agents
monoclonal anti
agents based
idiotypic antibody
idiotypic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22252/97A
Inventor
Linda Gillian Durrant
Richard Adrian Robins
Ian Spendlove
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604177.7A external-priority patent/GB9604177D0/en
Priority claimed from GBGB9604321.1A external-priority patent/GB9604321D0/en
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU2225297A publication Critical patent/AU2225297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
AU22252/97A 1996-02-28 1997-02-28 Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7 Abandoned AU2225297A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9604177.7A GB9604177D0 (en) 1996-02-28 1996-02-28 Therapeutic reagents
GB9604177 1996-02-28
GB9604321 1996-02-29
GBGB9604321.1A GB9604321D0 (en) 1996-02-29 1996-02-29 Therapeutic reagents
PCT/GB1997/000591 WO1997032021A1 (en) 1996-02-28 1997-02-28 Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7

Publications (1)

Publication Number Publication Date
AU2225297A true AU2225297A (en) 1997-09-16

Family

ID=26308818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22252/97A Abandoned AU2225297A (en) 1996-02-28 1997-02-28 Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7

Country Status (2)

Country Link
AU (1) AU2225297A (en)
WO (1) WO1997032021A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804065D0 (en) * 1998-02-26 1998-04-22 Cancer Res Campaign Tech Tumour associated antigen 791Tgp72
CA2481829A1 (en) * 2002-04-09 2003-10-16 Merck Patent Gesellschaft Mit Beschraenkter Haftung Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
US8034902B2 (en) 2005-05-04 2011-10-11 Quark Pharmaceuticals, Inc. Recombinant antibodies against CD55 and CD59 and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE130764T1 (en) * 1988-10-17 1995-12-15 Cancer Res Campaign Tech ANTI-IDIOTYPE ANTIBODIES INDUCTION OF AN ANTITUMOR RESPONSE.
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
US5227471A (en) * 1992-01-30 1993-07-13 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma

Also Published As

Publication number Publication date
WO1997032021A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
IL128406A0 (en) Monoclonal antibodies
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
EP0880597A4 (en) THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
AU1704099A (en) Monoclonal human natural antibodies
DK1516629T3 (en) Humanized anti-CD-11a antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU2645297A (en) Hepatitis b monoclonal antibodies
HUP9800613A3 (en) Humanized antibody against human fas-antigene
HUP9800744A3 (en) Antibodies against fas-antigene
EP0977590A4 (en) Human monoclonal antibodies
AU4256096A (en) Monoclonal antibody fragments having immunosuppressant activity
AU2539697A (en) Anti-idiotypic antibody vaccines
AU7572198A (en) Tumor-associated antigen
AU2225297A (en) Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7
GB9718911D0 (en) Monoclonal antibodies
AU1809695A (en) Tumor associated monoclonal antibody 123av16
AU2652897A (en) Anti-human mp52 monoclonal antibody
GB9515850D0 (en) Broad specificity antibodies
GB9615027D0 (en) Monoclonal antibodies
KR960032059U (en) Lighter combined use lighter
AU701885C (en) Monoclonal antibody active against CD44v6
GB9512314D0 (en) Antibody
GB9510603D0 (en) Antibody construct